CanSino Biologics Inc 2020 Annual Report with Sustainability Disclosures
Company: CanSino Biologics Inc
Sector: Manufacturing
Country: China
Year: 2020
Type: Annual Report with Sustainability Disclosures
Pages: 150
The report highlights CanSinoBIO's response to COVID-19, including the Ad5-nCoV vaccine's progression to a global multicenter phase III trial. It records the company's 2020 A-share listing on Shanghai's STAR Market, completing its A+H dual listing. The ESG section reports 733 employees, total energy consumption of 41,106.78 MWh, and total GHG emissions of 17,340.87 tCO2e from Scope 1 and 2.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.